The Lantern Pharma company management team consists of seasoned businessmen and entrepreneurs in the life science industry, with ample practical experience in drug development both inside and outside of oncology. As comfortable in the lab as they are presenting to the Board of Directors, our managers ensure the progress of cancer drug development through machine learning and artificial intelligence. You can find detailed bios on our Team page.
- Panna Sharma, President, Chief Executive Officer and Director
- David Margrave, Chief Financial Officer
- Kishor Bhatia, Ph.D, FRCPath, Chief Scientific Officer
- Kerry Barnhart, Ph.D, Vice President of Clinical Development
- Aditya Kulkarni, Ph.D, Senior Research Scientist & Program Manager
Let’s start a conversation about the future of cancer drug development.
We are a biotech pharma at the intersection of Artificial Intelligence, genomics, and oncology drug development.